Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Rishi, Deka"'
Publikováno v:
Journal of Fungi, Vol 9, Iss 7, p 731 (2023)
We describe the epidemiology of coccidioidomycosis among a national cohort of Veterans. Using electronic health record data from adults tested for coccidioidomycosis between 1 January 2013 and 31 December 2022, we analyzed differences in baseline dem
Externí odkaz:
https://doaj.org/article/8c8f3a9ded9e4ce5beee3e6a408bf7c7
Autor:
Ronda Lun, Danielle Carole Roy, Yu Hao, Rishi Deka, Wen-Kuan Huang, Babak B. Navi, Deborah M. Siegal, Tim Ramsay, Dean Fergusson, Risa Shorr, Dar Dowlatshahi
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundPatients newly diagnosed with cancer represent a population at highest risk for stroke. The objective of this systematic review and meta-analysis was to estimate the incidence of stroke in the first year following a new diagnosis of cancer.
Externí odkaz:
https://doaj.org/article/a7c8cc2130df49079f7bb687dc0df79f
Autor:
Joseph Biskupiak, Sudhir Unni, Claire Telford, Minkyoung Yoo, Xiangyang Ye, Rishi Deka, Diana Brixner, David Stenehjem
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Breast cancer costs were estimated at $16.5 billion in 2010 and were higher than other cancer costs. There are limited studies on breast cancer charges and costs by BRCA mutations and receptor status. We examined overall health ca
Externí odkaz:
https://doaj.org/article/d94ffe977e5144f598a1a1dd0daf5490
Autor:
Meghana S Pagadala, Julie Lynch, Roshan Karunamuni, Patrick R Alba, Kyung Min Lee, Fatai Y Agiri, Tori Anglin, Hannah Carter, J Michael Gaziano, Guneet Kaur Jasuja, Rishi Deka, Brent S Rose, Matthew S Panizzon, Richard L Hauger, Tyler M Seibert
Publikováno v:
JNCI: Journal of the National Cancer Institute. 115:190-199
Background Genetic scores may provide an objective measure of prostate cancer risk and thus inform screening decisions. We evaluated whether a polygenic hazard score based on 290 genetic variants (PHS290) is associated with prostate cancer risk in a
Publikováno v:
Journal of Fungi; Volume 9; Issue 7; Pages: 731
We describe the epidemiology of coccidioidomycosis among a national cohort of Veterans. Using electronic health record data from adults tested for coccidioidomycosis between 1 January 2013 and 31 December 2022, we analyzed differences in baseline dem
Autor:
Matthew S. Panizzon, Rishi Deka, Tori Anglin, Mark W. Logue, Victoria Merritt, Nai‐Chung N Chang, Hannah K Carter, Guneet Jasuja, Kyung‐Min Lee, Julie Lynch, Meghana Pagadala, Brenton Rose, Tyler Seibert, Craig Teerlink, Xin M Tu, Richard L. Hauger
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Brent S. Rose, Daniel R Cherry, A. Karim Kader, Tyler F. Stewart, Anthony T. Yip, Tyler J. Nelson, J. Kellogg Parsons, Elaine Luterstein, Nikhil V. Kotha, Rishi Deka, Mia A. Salans, Abhishek Kumar, P Travis Courtney, Vinit Nalawade
Publikováno v:
Cancer. 127:4403-4412
BACKGROUND The safety of active surveillance (AS) for African American men compared with non-Hispanic White (White) men with intermediate-risk prostate cancer is unclear. METHODS The authors identified patients with modified National Comprehensive Ca
Autor:
Jerzy E. Tyczynski, Lia Gutierrez, Rishi Deka, Amy Sainski, Junjie Ma, Tapashi Dalvi, David D. Stenehjem, Casey R. Tak, Marisa B. Schauerhamer, Claire Telford, Joseph Biskupiak, James A. Kaye, Sudhir Unni, Diana I. Brixner, Hillevi Bauer, Xiangyang Ye
Publikováno v:
Breast Cancer Research and Treatment. 186:839-850
Germline BRCA mutations (BRCAm) strongly influence the risk of developing breast cancer. This study aimed to understand the role of BRCAm testing in affected individuals and to assess its impact on the outcome of BRCAm carriers compared to non-carrie
Autor:
Rana R. McKay, Reith R Sarkar, Rishi Deka, Sunil Patel, Paul Riviere, Brent S. Rose, James D. Murphy, Christopher J. Kane, A. Karim Kader, John P. Einck, Arno J. Mundt, Abhishek Kumar, J. Kellogg Parsons
Publikováno v:
Prostate Cancer and Prostatic Diseases. 23:689-695
Background The safety of testosterone therapy (TT) after definitive treatment for localized prostate cancer remains undefined. We analyzed the risks of biochemical recurrence and mortality in men receiving TT after treatment for localized prostate ca
Autor:
Chelsea S Rock, Brent S. Rose, Christopher J. Kane, James D. Murphy, Rishi Deka, Lucas K. Vitzthum, Paul Riviere, Daniel R. Simpson, J. Kellogg Parsons, Vinit Nalawade, A. Karim Kader
Publikováno v:
Prostate Cancer and Prostatic Diseases. 23:581-588
There is concern that African-American men (AA) with low-risk prostate cancer may present with more aggressive disease and thus may not be candidates for active surveillance (AS). However, it is uncertain if poorer outcomes are due to disparities in